Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.918 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8729 |
High Similarity |
NPD228 |
Approved |
0.8607 |
High Similarity |
NPD5536 |
Phase 2 |
0.8583 |
High Similarity |
NPD5283 |
Phase 1 |
0.8462 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8308 |
Intermediate Similarity |
NPD9494 |
Approved |
0.825 |
Intermediate Similarity |
NPD3022 |
Approved |
0.825 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8175 |
Intermediate Similarity |
NPD1651 |
Approved |
0.8085 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7985 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7959 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7941 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD1283 |
Approved |
0.791 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7907 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7868 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7868 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7852 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7842 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7838 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7794 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7737 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7737 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD2684 |
Approved |
0.771 |
Intermediate Similarity |
NPD1281 |
Approved |
0.771 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7708 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7674 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7652 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7652 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7652 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7615 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7603 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7594 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7594 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7559 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7557 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7551 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7542 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7537 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7533 |
Intermediate Similarity |
NPD37 |
Approved |
0.7519 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3020 |
Approved |
0.75 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD826 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7482 |
Intermediate Similarity |
NPD943 |
Approved |
0.7482 |
Intermediate Similarity |
NPD825 |
Approved |
0.7482 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7481 |
Intermediate Similarity |
NPD2797 |
Approved |
0.748 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7465 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7464 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7464 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7464 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7464 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7458 |
Intermediate Similarity |
NPD9296 |
Approved |
0.745 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7442 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7434 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7429 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7426 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD258 |
Approved |
0.7426 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7426 |
Intermediate Similarity |
NPD257 |
Approved |
0.7424 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7424 |
Intermediate Similarity |
NPD17 |
Approved |
0.7421 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7386 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7381 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7372 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7348 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7472 |
Approved |
0.731 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7293 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7286 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD259 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.728 |
Intermediate Similarity |
NPD968 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7254 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD824 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7206 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7203 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7194 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7192 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7183 |
Intermediate Similarity |
NPD555 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7171 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7164 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7164 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7164 |
Intermediate Similarity |
NPD2667 |
Approved |
0.716 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7134 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7124 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7124 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD9569 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7111 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD3023 |
Approved |
0.7111 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.709
|
Intermediate Similarity |
NPD3025 |
Approved |